GORDON CARL L (CIK 1282930) reported 9 SEC Form 4 insider transactions across 4 companies over the past 18 months (most recent 2026-08-12). Recent activity: Buy BLSM (1.0M shares), Buy BLSM (1.0M shares), Buy BLSM (625,000 shares), Buy SCTX (348,825 shares), Buy SCTX (1.0M shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-12 | BlossomHill Therapeutics, Inc. (BLSM) | Director | Buy | 1.0M | $0 |
| 2026-08-12 | BlossomHill Therapeutics, Inc. (BLSM) | Director | Buy | 1.0M | $0 |
| 2026-08-12 | BlossomHill Therapeutics, Inc. (BLSM) | Director | Buy | 625,000 | $10.0M |
| 2026-07-29 | Scribe Therapeutics, Inc. (SCTX) | Director | Buy | 348,825 | $0 |
| 2026-07-29 | Scribe Therapeutics, Inc. (SCTX) | Director | Buy | 1.0M | $15.0M |
| 2025-12-18 | Keros Therapeutics, Inc. (KROS) | Director | Sell | 140,057 | $2.5M |
| 2025-12-18 | Keros Therapeutics, Inc. (KROS) | Director | Sell | 74,465 | $1.3M |
| 2025-06-06 | Keros Therapeutics, Inc. (KROS) | Director | Buy | 5,250 | $0 |
| 2025-04-11 | Compass Therapeutics, Inc. (CMPX) | Director | Sell | 3.6M | $5.7M |
Source: SEC Form 4 filings · as of 2026-08-12